Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Primary Brain Cancer
2.
Drug Delivery Global Industry Guide
3.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
4.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
5.
BioNewsCast Press Release Distribution Service
6.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
7.
Cell Therapy - Technologies, Markets and Companies
8.
Cytogenetics - technologies, markets and companies
9.
Molecular Diagnostics Markets
10.
The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
Abdominal Aortic Aneurysm Endovascular Technology and Market Forecasts
It is estimated that approximately 4.5 million people in the developed word are living with an abdominal aortic aneurysm and each year 600,000 new cases are diagnosed.
Patients typically have no symptoms and, when they are diagnosed, they often undergo complex open surgical repair. Stent-graft therapy provides a minimally-invasive alternative, with reduced recovery times and potentially improved survival rates.
By the end of 2006 the global market for abdominal aortic aneurysm stent-grafts has reached US$610 million and has been growing at double digit rate.
Technical improvements in graft design and advancement in delivery techniques will result in the increased application of Endovascular Aneurysm Repair (EVAR) and the market is expected to reach US$1.3 billion by 2012.
Medtech Ventures' Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is an exclusive introduction to this rapidly growing market.
The report provides a brief, but through, analysis of this market with profiles of leading participants and forecasts to the year 2012.
With Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast, you'll be able to better:
- Identify emerging technologies and the companies behind them.
- Leverage your own technology and brain storm new business opportunities.
- Assess market size and growth potential.
- Understand current market dynamics, competitors positions and market shares.
- Assess market potential and have access to forecasts till 2012.
- Monitor the competition's marketed and in-development products.
- Investigate mergers, acquisitions and licensing possibilities
Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area.
Date Published: July 2007
Number of Pages: 22
PDF Format
Table of Contents
Price
PDF Single User $950.00
PDF Site Licence $1900.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.